Double trouble: A case of spinal muscular atrophy type III found to be complicated by myasthenia gravis due to subacute dysphagia

Q4 Immunology and Microbiology
Ruoyi Ishikawa, Takamichi Sugimoto, Takafumi Abe, Narumi Ohno, Mayumi Giga, Hiroyuki Naito, Tomoyuki Kono, Eiichi Nomura, Takemori Yamawaki
{"title":"Double trouble: A case of spinal muscular atrophy type III found to be complicated by myasthenia gravis due to subacute dysphagia","authors":"Ruoyi Ishikawa,&nbsp;Takamichi Sugimoto,&nbsp;Takafumi Abe,&nbsp;Narumi Ohno,&nbsp;Mayumi Giga,&nbsp;Hiroyuki Naito,&nbsp;Tomoyuki Kono,&nbsp;Eiichi Nomura,&nbsp;Takemori Yamawaki","doi":"10.1111/cen3.12707","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Spinal muscular atrophy (SMA) is a genetic disorder caused by the progressive loss of lower motor neurons. Myasthenia gravis (MG) is an acquired, autoimmune, neuromuscular junction disorder. We encountered a rare case of coexisting SMA and MG.</p>\n </section>\n \n <section>\n \n <h3> Case Presentation</h3>\n \n <p>A man was diagnosed with SMA type III when aged in his 20s. At the age 71 years, he started experiencing difficulty flexing his elbow, with dysphagia appearing within a few months. He had difficulty eating and was referred to our hospital to undergo gastrostomy. Other diseases that could cause dysphagia were investigated. Tests for acetylcholine receptor antibody and edrophonium showed positive results, based on which he was diagnosed with MG. A genetic test was carried out that reconfirmed SMA. He was treated with intravenous methylprednisolone, pyridostigmine and tacrolimus, resulting in dysphagia gradually recovering and he could consume a full meal. The patient was discharged without undergoing gastrostomy.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>SMA type III is a disease manifesting as slowly progressive muscle weakness. When the muscle weakness progresses and dysphagia appears subacutely in SMA type III patients, it is necessary to consider the complications of other diseases, such as MG.</p>\n </section>\n </div>","PeriodicalId":10193,"journal":{"name":"Clinical and Experimental Neuroimmunology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Neuroimmunology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cen3.12707","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Immunology and Microbiology","Score":null,"Total":0}
引用次数: 1

Abstract

Background

Spinal muscular atrophy (SMA) is a genetic disorder caused by the progressive loss of lower motor neurons. Myasthenia gravis (MG) is an acquired, autoimmune, neuromuscular junction disorder. We encountered a rare case of coexisting SMA and MG.

Case Presentation

A man was diagnosed with SMA type III when aged in his 20s. At the age 71 years, he started experiencing difficulty flexing his elbow, with dysphagia appearing within a few months. He had difficulty eating and was referred to our hospital to undergo gastrostomy. Other diseases that could cause dysphagia were investigated. Tests for acetylcholine receptor antibody and edrophonium showed positive results, based on which he was diagnosed with MG. A genetic test was carried out that reconfirmed SMA. He was treated with intravenous methylprednisolone, pyridostigmine and tacrolimus, resulting in dysphagia gradually recovering and he could consume a full meal. The patient was discharged without undergoing gastrostomy.

Conclusions

SMA type III is a disease manifesting as slowly progressive muscle weakness. When the muscle weakness progresses and dysphagia appears subacutely in SMA type III patients, it is necessary to consider the complications of other diseases, such as MG.

双重困扰:一例脊髓性肌萎缩型 III亚急性吞咽困难并发重症肌无力
脊髓性肌萎缩(SMA)是一种由下运动神经元进行性丧失引起的遗传性疾病。重症肌无力(MG)是一种获得性、自身免疫性、神经肌肉接头疾病。我们遇到了罕见的SMA和MG共存的病例。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical and Experimental Neuroimmunology
Clinical and Experimental Neuroimmunology Immunology and Microbiology-Immunology and Microbiology (miscellaneous)
CiteScore
1.60
自引率
0.00%
发文量
52
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信